We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Perfusion Technique May Save Cardiac Arrest Patients

By HospiMedica staff writers
Posted on 19 Nov 2001
An experimental procedure for delivering oxygen to the heart after cardiac arrest may keep the victims alive long enough for doctors to repair the damage and prevent them from dying. More...
The procedure was reported in the November 2001 issue of Critical Care Medicine by researchers at the University of North Carolina at Chapel Hill (UNC, USA).

The procedure, called selective aortic arch perfusion (SAAP), employs a specialized balloon catheter to pump an oxygen-carrying fluid into the aorta. The fluid is HBOC-201, a hemoglobin-based oxygen carrier developed by Biopure Corp. (Cambridge, MA, USA). When the balloon is inflated, the oxygenated fluid is pumped in, perfusing the upper part of the body. The study involved a pig model of liver injury and severe bleeding. A blood pressure drop caused the animals' hearts to stop beating. Six of the animals were treated with SAAP and HBOC-201, and six were treated with SAAP and a saline solution. Spontaneous heartbeat with sustained aortic blood pressure occurred only in those animals that received the HBOC-201 solution. More animal studies are needed, to confirm the procedure's benefits, say the researchers.

"Cardiac arrest due to blood loss, hemorrhage, especially after blunt trauma, has an almost 100% mortality,” said James E. Manning, M.D., associate professor of emergency medicine at UNC School of Medicine and one of the study's co-authors. "If you can keep somebody like this alive, you may be able to get them to an operating room, stop the bleeding, and repair the damage.”





Related Links:
Univ. of North Carolina
Biopure

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.